Trials / Sponsors / Zogenix MDS, Inc.
Zogenix MDS, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve) Thymidine Kinase 2 Deficiency | Phase 3 | 2022-09-30 |
| Completed | A Retrospective Study of Subjects With Thymidine Kinase 2 Deficiency Thymidine Kinase 2 Deficiency | — | 2021-07-23 |
| Completed | A RETROspective Study of Patients With TK2d Thymidine Kinase 2 (TK2) | — | 2018-11-19 |